N-[2-异丙基噻唑-4-甲基氨基甲酰]-L-缬氨酸

Ureidovaline

产品编号.: A212610 CAS号: 154212-61-0
分子式: C14H23N3O3S 分子量: 313.4157
纯度: 98% MDL NO.:

中文名称:N-[2-异丙基噻唑-4-甲基氨基甲酰]-L-缬氨酸
CAS号:154212-61-0
中文别名:N-[2-异丙基噻唑-4-甲基氨基甲酰]-L-缬氨酸;N-[N-甲基-N-[(2-异丙基-4-噻唑基)甲基]氨基羰基]-L-缬氨酸;(S)-2-(3-((2-异丙基噻唑-4-基)甲基)-3-甲基脲)-3-甲基丁酸,;N-((N-甲基-N-((2-异丙基-4-噻唑基)甲基)氨基)羰基)-L-缬氨酸;N-[2-异丙基噻唑-4-基甲基(甲基)氨基甲酰基] -L-缬氨酸;N-[N-甲基-N-((2-异丙基-4-噻唑基)甲基)氨基)羰基]-L-缬氨酸;利托那韦中间体MTV-III;N-[2-异丙基噻唑-4-甲基氨基甲酰]-L-缬氨酸(MTVIII);(MTV-III)N-[N-甲基-N-((2-异丙基-4-噻唑基)甲基)氨基)羰基]-L-缬氨酸;N-[[N-甲基-N-[(2-异丙基-4-噻唑基)甲基]氨基]羰基]-L-缬氨酸(MTV III)
英文名称:Ureidovaline
英文别名:N-[2-Isopropylthiazol-4-ylmethyl(methyl)carbamoyl]-L-valine;(s)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanoic acid;N-{[N-methyl-N-[(2-isopropyl-4-thiazolyl)methyl]-N-methyl]amino}carbony-L-valine;N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)-L-valine;N-[[N-Methyl-N-[(2-isopropyl]-4-thiazolyl)Methyl)aMino]carbonyl-L-valine Carboxylic Acid;N-[2-Isopropylthiazol-4-ylmethyl-(methyl)carbamoyl]-L-valine;Ureidovaline;MTV-III;MTV;N-[N-[(2-isopropyl-4-thiazole)Methyl]-N-Methyl]car;L-Valine,N-[[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]-;MTV-III N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)Methyl)aMino)carbonyl)-L-valine;(MTV-III) N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)Methyl)aMino)carbonyl)-L-valin;N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)Methyl)aMino)carbonyl)-L-valine (MTV-III);10433TZP2U;(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoic Acid;L-Valine, N-((methyl((2-(1-methylethyl)-4-thiazolyl)methyl)amino)carbonyl)-;(2S)-3-Methyl-2-((methyl((2-(1-methylethyl)th
EINEC:
分子式:C14H23N3O3S
分子量:313.42
搜索质检报告(COA)
搜索MSDS
已经到最底了
批量搜索 关闭
批处理可以通过CAS号,CAS号,每行一个搜索
...

N-[2-异丙基噻唑-4-甲基氨基甲酰]-L-缬氨酸
N-[2-Isopropylthiazol-4-ylmethyl(methyl)carbamoyl]-L-valine;(s)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanoic acid;N-{[N-methyl-N-[(2-isopropyl-4-thiazolyl)methyl]-N-methyl]amino}carbony-L-valine;N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)-L-valine;N-[[N-Methyl-N-[(2-isopropyl]-4-thiazolyl)Methyl)aMino]carbonyl-L-valine Carboxylic Acid;N-[2-Isopropylthiazol-4-ylmethyl-(methyl)carbamoyl]-L-valine;Ureidovaline;MTV-III;MTV;N-[N-[(2-isopropyl-4-thiazole)Methyl]-N-Methyl]car;L-Valine,N-[[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]-;MTV-III N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)Methyl)aMino)carbonyl)-L-valine;(MTV-III) N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)Methyl)aMino)carbonyl)-L-valin;N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)Methyl)aMino)carbonyl)-L-valine (MTV-III);10433TZP2U;(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoic Acid;L-Valine, N-((methyl((2-(1-methylethyl)-4-thiazolyl)methyl)amino)carbonyl)-;(2S)-3-Methyl-2-((methyl((2-(1-methylethyl)th